Earlier this month Martin Shkreli, who became a household name in 2015 when, he as CEO of a tiny company called Turing Pharmaceuticals, raised the price of a drug used to treat a parasitic infection by more than 5,000%, was sentenced to seven years in prison for defrauding investors in two failed hedge funds.
- Black Friday Physical Store Sales Turn Out Better Than Expected
- Entitlements: The “Most Predictable Economic Crisis In History”
- Corporate Gross Debt Reduction Could Spell Trouble For Credit Markets
Login required to continue reading.
Setup a free account to get access to this article (no credit card required).
View Full ArticleAlready a member? Log in here
